AMENDMENT #1 (FEBRUARY 2005 AMENDED AND RESTATED LICENSE AGREEMENT)
Exhibit
10.5
AMENDMENT
#1
(FEBRUARY
2005 AMENDED AND RESTATED LICENSE AGREEMENT)
This
amendment #1, effective as of the 31st day of
January 2007, amends the February 1, 2005 Amended and Restated License Agreement
entered into and between ALLEGHENY-SINGER
RESEARCH INSTITUTE, a Pennsylvania nonprofit corporation with an address
at 000 Xxxx Xxxxx Xxxxxx, Xxxxxxxxxx, Xxxxxxxxxxxx 00000 (“ASRI”), and Omnimmune
Corp., a Texas corporation located at 0000 Xxxx Xxx Xxxxx, Xxxxx 000, Xxxxxxx,
Xxxxx 00000 (“Company”) according to the following terms and
conditions:
|
1)
|
Paragraph
3e is hereby modified to extend for an additional three months, the
payment of the annual license maintenance fees due on February 1, 2007;
therefore, the payment shall be due on or before May 1,
2007.
|
|
2)
|
The
following paragraphs are hereby modified to extend each date thereof an
additional eighteen months:
|
|
a.
|
6a(i),
|
|
b.
|
6a(iii),
|
|
c.
|
6a(iv)(a),
6a(iv)(b), 6a(iv)(c),
|
|
d.
|
6a(v)(a),
6a(v)(b), 6a(v)(c), 6a(v)(d)
|
All other
terms and conditions of the original License Agreement shall remain in full
force and effect.
IN WITNESS WHEREOF, the parties have executed
this Agreement in multiple originals as of the date set out below next to their
signatures.
OMNIMMUNE CORP.
ALLEGHENY-SINGER RESEARCH
INSTITUTE
/s/ Xxxxxx X.
Xxxxxxxxxxxx
/s/ Xxxxxx Xxxxx
Xxxxxx X.
Xxxxxxxxxxxx,
Ph.D. Xxxxxx
Xxxxx
President
Director, Office of Sponsored Research
Date:
3/27/07
Date: 3-26-07
